Literature DB >> 27771931

Evodiamine and Its Role in Chronic Diseases.

Qunyou Tan1, Jingqing Zhang2.   

Abstract

Evodiamine (EVO) is a major alkaloid compound extracted from the dry unripened fruit Evodiae fructus (Evodia rutaecarpa Benth., Rutaceae). EVO has a variety of pharmacological activities, such as anti-obesity, anti-allergenic, analgesic, anti-tumor, anti-ulcerogenic, and neuroprotective activities. EVO has varying efficacies in animal models and humans. Here, the physicochemical properties of EVO are presented, and the EVO's functions and mechanisms of action in various chronic diseases are reviewed. EVO is worth exploring in more depth in the future for its potential use in various chronic diseases.

Entities:  

Keywords:  Cell signaling pathways; Chronic diseases; Evodiamine; Mechanisms of action; Pharmacological activities; Physico-chemical properties

Mesh:

Substances:

Year:  2016        PMID: 27771931     DOI: 10.1007/978-3-319-41342-6_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.

Authors:  Nasreddine El Omari; Saad Bakrim; Mohamed Bakha; José M Lorenzo; Maksim Rebezov; Mohammad Ali Shariati; Sara Aboulaghras; Abdelaali Balahbib; Mars Khayrullin; Abdelhakim Bouyahya
Journal:  Nutrients       Date:  2021-10-22       Impact factor: 5.717

2.  An Indole Alkaloid Extracted from Evodia rutaecarpa Inhibits Colonic Motility of Rats In Vitro.

Authors:  Guo-Xiang Wang; Yan-Li Xiang; Hong-Gang Wang; Yang-de Miu; Guang Yu
Journal:  Gastroenterol Res Pract       Date:  2020-04-03       Impact factor: 2.260

3.  Effect of Evodiamine on Rat Colonic Hypermotility Induced by Water Avoidance Stress and the Underlying Mechanism.

Authors:  HaiXia Ren; FangTing Yuan; Wei Tan; YiJuan Ding; Ping An; HeSheng Luo
Journal:  Drug Des Devel Ther       Date:  2021-02-10       Impact factor: 4.162

4.  Peroxidase-mimicking evodiamine/indocyanine green nanoliposomes for multimodal imaging-guided theranostics for oral squamous cell carcinoma.

Authors:  Zheng Wei; Huihui Zou; Gongyuan Liu; Chuanhui Song; Chuanchao Tang; Sheng Chen; Guorong Zhang; Jianchuan Ran; Yufeng Wang; Xiteng Yin; Yu Cai; Wei Han
Journal:  Bioact Mater       Date:  2021-01-13

5.  Effect of Evodiamine on Collagen-Induced Platelet Activation and Thrombosis.

Authors:  Xiaona Yang; Min Leng; Lihong Yang; Yunzhu Peng; Jing Wang; Qian Wang; Kun Wu; Junhua Zou; Wen Wan; Longjun Li; Yujia Ye; Zhaohui Meng
Journal:  Biomed Res Int       Date:  2022-07-27       Impact factor: 3.246

Review 6.  Plant and fungi derived analgesic natural products targeting voltage-gated sodium and calcium channels.

Authors:  Aida Calderon-Rivera; Santiago Loya-Lopez; Kimberly Gomez; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2022-12       Impact factor: 3.493

7.  Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs.

Authors:  Shan Liu; Dilong Chen; Yuming Yuan; Xue Zhang; Yao Li; Shenglei Yan; Jingqing Zhang
Journal:  Oncotarget       Date:  2017-04-28

8.  Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo.

Authors:  Tao Su; Xia Yang; Jian-Hua Deng; Qiu-Ju Huang; Su-Chao Huang; Yan-Min Zhang; Hong-Ming Zheng; Ying Wang; Lin-Lin Lu; Zhong-Qiu Liu
Journal:  Front Pharmacol       Date:  2018-05-01       Impact factor: 5.810

Review 9.  Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives.

Authors:  Xu Hu; Dahong Li; Chun Chu; Xu Li; Xianhua Wang; Ying Jia; Huiming Hua; Fanxing Xu
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

10.  Improved delivery of natural alkaloids into lung cancer through woody oil-based emulsive nanosystems.

Authors:  Jing Zhao; Shan Liu; Xueyuan Hu; Yunmei Zhang; Shenglei Yan; Hua Zhao; Mei Zeng; Yao Li; Lan Yang; Jingqing Zhang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.